UK markets closed
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • FTSE 250

    20,593.46
    -21.23 (-0.10%)
     
  • AIM

    889.79
    +1.03 (+0.12%)
     
  • GBP/EUR

    1.1163
    -0.0042 (-0.37%)
     
  • GBP/USD

    1.2056
    -0.0173 (-1.41%)
     
  • BTC-GBP

    19,377.64
    -166.60 (-0.85%)
     
  • CMC Crypto 200

    535.42
    -1.43 (-0.27%)
     
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • DOW

    33,926.01
    -127.93 (-0.38%)
     
  • CRUDE OIL

    73.23
    -2.65 (-3.49%)
     
  • GOLD FUTURES

    1,865.90
    -50.40 (-2.63%)
     
  • NIKKEI 225

    27,509.46
    +107.41 (+0.39%)
     
  • HANG SENG

    21,660.47
    -297.89 (-1.36%)
     
  • DAX

    15,476.43
    -32.76 (-0.21%)
     
  • CAC 40

    7,233.94
    +67.67 (+0.94%)
     

Stem Cell Therapy Global Market Report 2022: Increasing R&D and Healthcare Expenditure Bolsters Sector

Company Logo
Company Logo

Global Stem Cell Therapy Market

Global Stem Cell Therapy Market
Global Stem Cell Therapy Market

Dublin, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The "Stem cell therapy Market By Cell Source, By Application, By Type: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

The global stem cell therapy market was valued at $205.12 million in 2021, and is projected to reach $928.64 million by 2031, registering a CAGR of 16.2% from 2022 to 2031.

Stem cell therapy is a promising strategy for regeneration of damaged organs, tissues or functions through the transplantation of stem cells. The cell therapy involves the direct administration of cells into the body for healing purposes. The units of therapy in this approach are single cells. It has been established as a useful therapy for hematologic malignancies and some solid tumors.

However, some of the patients still die in allogeneic stem cell transplantation because T-lymphocytes cause fatal GVHD, and many are not cured in autologous stem cell transplantation as the disease recurs post-stem cell transplantation. Hematopoietic stem cell therapies provide methods for inducing lifelong tolerance to xenografts or allow novel treatment of autoimmune diseases, whereas the research and use of nonhematopoietic stem cells help minimize the toxicities of cancer therapy or cure non-malignant disorders.

The global stem cell therapy market is anticipated to show significant market growth during the forecast period, owing to increase in demand for stem cell therapy, increase in government support for R&D activities and increase in healthcare expenditure. Furthermore, increase in prevalence of diseases such as cancer, and new product launches associated with stem cell therapy are considerably contributing toward the market growth.

However, limitations on use of embryonic stem cells due to ethical concerns and high cost of stem cell therapy are negatively impacting the market growth. Conversely, surge in the applications of induced pluripotent stem cells in embryonic stem cell therapy offers the lucrative opportunities for the growth of the market.

Report Attribute

Details

No. of Pages

274

Forecast Period

2021 - 2031

Estimated Market Value (USD) in 2021

$205.12 million

Forecasted Market Value (USD) by 2031

$928.64 million

Compound Annual Growth Rate

16.3%

Regions Covered

Global

Key Market Segments
By Cell Source

  • Adipose Tissue-Derived Mesenchymal Stem Cells

  • Bone Marrow-Derived Mesenchymal Stem Cells

  • Cord Blood/Embryonic Stem Cells

  • Other

By Application

  • Cancer

  • Musculoskeletal Disorder

  • Wounds and Injuries

  • Cardiovascular Disease

  • Other

By Type

  • Allogeneic Transplants

  • Age

  • Pediatric

  • Adult

  • Autologous Transplants

  • Age

  • Pediatric

  • Adult

By Region

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • UK

  • Rest Of Europe

  • Asia-Pacific

  • Japan

  • India

  • South Korea

  • Rest Of Asia-Pacific

  • LAMEA

  • Brazil

  • Rest Of LAMEA

Key Market Players

  • Allele Biotechnology and Pharmaceuticals, Inc.

  • Astellas Pharma Inc.

  • Fujifilm Holding Corporation

  • Mesoblast Ltd.

  • Novadip Biosciences

  • NuVasive, Inc.

  • Orthofix Holdings, Inc.

  • Smith & Nephew plc

  • Takeda Pharmaceutical Company Ltd

  • U.S. Stem Cell, Inc.

KEY FINDINGS OF STUDY

  • By product & services, the consumable segment accounted for major microarray market share in 2021.

  • By type, the protein microarray segment is anticipated to grow with the highest CAGR throughout the forecast period.

  • By end user, the research and academic institutes segment is anticipated to grow with the highest CAGR of 8.5% throughout the forecast period.

  • By region, North America occupied major share of the global microarray industry in 2021.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: STEM CELL THERAPY MARKET, BY CELL SOURCE

CHAPTER 5: STEM CELL THERAPY MARKET, BY APPLICATION

CHAPTER 6: STEM CELL THERAPY MARKET, BY TYPE

CHAPTER 7: STEM CELL THERAPY MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

For more information about this report visit https://www.researchandmarkets.com/r/c0zkg0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900